We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

26 hedge funds and large institutions have $10.9M invested in Marker Therapeutics in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $8.82M → $10.9M (+$2.07M)

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

0.24% more ownership

Funds ownership: 22.04% → 22.29% (+0.24%)

7% less funds holding

Funds holding: 28 → 26 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
–
Increased
6
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$94.3K
2
WS
Wedbush Securities
California
+$38.8K
3
Morgan Stanley
Morgan Stanley
New York
+$17.8K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$13.5K
5
TRCT
Tower Research Capital (TRC)
New York
+$2.32K

Top Sellers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
-$13.6K
2
Renaissance Technologies
Renaissance Technologies
New York
-$9.15K
3
Bank of America
Bank of America
North Carolina
-$3K
4
MA
MCF Advisors
Kentucky
-$2.77K
5
JP Morgan Chase
JP Morgan Chase
New York
-$2.71K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$5.89M – – –
ACM
2
Aisling Capital Management
New York
$1.73M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.24M +$13.5K +3,975 +2%
AAM
4
AR Asset Management
California
$389K – – –
WS
5
Wedbush Securities
California
$382K +$38.8K +11,438 +20%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$330K – – –
Northern Trust
7
Northern Trust
Illinois
$213K +$94.3K +27,830 +256%
Renaissance Technologies
8
Renaissance Technologies
New York
$207K -$9.15K -2,700 -7%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$112K – – –
State Street
10
State Street
Massachusetts
$109K – – –
Creative Planning
11
Creative Planning
Kansas
$95.2K – – –
MAA
12
Matrix Asset Advisors
New York
$82.5K – – –
Morgan Stanley
13
Morgan Stanley
New York
$39.6K +$17.8K +5,256 +271%
Osaic Holdings
14
Osaic Holdings
Arizona
$35.1K -$13.6K -4,027 -39%
Bank of America
15
Bank of America
North Carolina
$12.8K -$3K -886 -28%
RAM
16
Riggs Asset Management
Pennsylvania
$8.8K -$2.54K -750 -32%
BlackRock
17
BlackRock
New York
$7.5K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$7.22K +$2.32K +685 +109%
US Bancorp
19
US Bancorp
Minnesota
$4.62K – – –
Wells Fargo
20
Wells Fargo
California
$1.56K +$10 +3 +1%
Group One Trading
21
Group One Trading
Illinois
$979 – – –
HNB
22
Huntington National Bank
Ohio
$385 – – –
JP Morgan Chase
23
JP Morgan Chase
New York
$182 -$2.71K -801 -96%
VCM
24
Versant Capital Management
Arizona
$83 – – –
Fidelity Investments
25
Fidelity Investments
Massachusetts
$66 – – –
1
2

MRKR Hedge Fund Activity: Q4 2023 in Review

26 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q4 2023, worth a combined $10.9M — up 24% from $8.82M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of MRKR and 0 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 6 added.

The largest buyer was Northern Trust, adding an estimated $94.3K. The largest seller was Osaic Holdings, cutting an estimated $13.6K.

  • 26 institutional investors held Marker Therapeutics (MRKR) as of Q4 2023, down from 28 in Q3 2023.
  • Funds reported $10.9M of Marker Therapeutics stock for Q4 2023, up 24% quarter-over-quarter.
  • 0 funds opened new Marker Therapeutics positions in Q4 2023 and 2 closed out, a net change of -2 holders.
  • The largest Marker Therapeutics buyer in Q4 2023 was Northern Trust, an estimated $94.3K added.
  • The largest Marker Therapeutics seller in Q4 2023 was Osaic Holdings, an estimated $13.6K sold.

Based on aggregated 13F filings for Q4 2023.